The European Union's pharmaceutical sector is in a constant state of progression. With rigorous regulations, growing patient demands, and the accelerated pace of innovation, navigating this challenging landscape requires a strategic approach. Pharmaceutical companies must evolve to this changes by implementing cutting-edge technologies, working wit